Skip to content

Effect of concurrent peripheral nerve stimulation therapy on upper limb function and improvement in the daily living activities of chronic stage stroke patients undergoing low-frequency repetitive transcranial magnetic stimulation therapy and occupational therapy

Effect of concurrent peripheral nerve stimulation therapy on upper limb function and improvement in the daily living activities of chronic stage stroke patients undergoing low-frequency repetitive transcranial magnetic stimulation therapy and occupational therapy - Effect of concurrent peripheral nerve stimulation therapy on upper limb function and improvement in the daily living activities of chronic stage stroke patients undergoing low-frequency repetitive transcranial magnetic stimulation therapy and occupational therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030080
Enrollment
30
Registered
2017-11-22
Start date
2017-11-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Apply one hour per day of PNS therapy to the forearm of the paralyzed side of the body during OT to stroke patients with upper limb paralysis who are undergoing r-TMS therapy and 2-week intensive OT.

Sponsors

Shinshu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged 20 years or older at the time consent was obtained. Ability to voluntarily extend at least three fingers, including the thumb. Ability to raise the arm on the affected side to the level of the nipple or higher. Six months or more have passed since the onset of stroke. PNS therapy has been prescribed by the patient's physician. Patients who gave voluntary written informed consent after receiving an adequate explanation regarding their participation in the study.

Exclusion criteria

Exclusion criteria: Severe aphasia, agnosia, apraxia, or other severe higher brain dysfunction that interferes with the procedures of the study. Cutaneous anesthesia. Having an inflammatory disease with arthritic inflammation, such as rheumatoid arthritis. Previous participation in this study. Previous history of receiving concurrent PNS therapy with r-TMS therapy. Patients who have otherwise been determined to be ineligible as a subject by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Wolf motor function test

Secondary

MeasureTime frame
Fugl-Meyer Assessment Motor Activity Log

Countries

Japan

Contacts

Public ContactHitoshi Mutai

Shinshu University Division of occupational therapy, School of health sciences, Faculty of Medicine

hitmutai@shinshu-u.ac.jp0263-37-2405

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026